MUELLER PETER 4
4 · BioXcel Therapeutics, Inc. · Filed Aug 23, 2019
Insider Transaction Report
Form 4
MUELLER PETER
Director
Transactions
- Purchase
Common Stock
2019-08-21$8.42/sh+1,800$15,156→ 160,120 total - Purchase
Common Stock
2019-08-22$8.83/sh+6,646$58,684→ 166,766 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. The shares were acquired in multiple transactions at prices ranging from $8.29 to $8.46, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth in this footnote.
- [F2]The price reported in Column 4 is a weighted average price. The shares were acquired in multiple transactions at prices ranging from $8.43 to $9.09, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the SEC, upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth in this footnote.